These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 30190369)
1. A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma. Goyal L; Zheng H; Abrams TA; Miksad R; Bullock AJ; Allen JN; Yurgelun MB; Clark JW; Kambadakone A; Muzikansky A; Knowles M; Galway A; Afflitto AJ; Dinicola CF; Regan E; Hato T; Mamessier E; Shigeta K; Jain RK; Duda DG; Zhu AX Clin Cancer Res; 2019 Jan; 25(1):80-89. PubMed ID: 30190369 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients. Coriat R; Mir O; Cessot A; Brezault C; Ropert S; Durand JP; Cacheux W; Chaussade S; Goldwasser F Invest New Drugs; 2012 Feb; 30(1):376-81. PubMed ID: 20798975 [TBL] [Abstract][Full Text] [Related]
3. Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1). Lyu N; Wang X; Li JB; Lai JF; Chen QF; Li SL; Deng HJ; He M; Mu LW; Zhao M J Clin Oncol; 2022 Feb; 40(5):468-480. PubMed ID: 34905388 [TBL] [Abstract][Full Text] [Related]
4. A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma. Lee DW; Lee KH; Kim HJ; Kim TY; Kim JS; Han SW; Oh DY; Kim JH; Im SA; Kim TY BMC Cancer; 2018 Mar; 18(1):252. PubMed ID: 29506478 [TBL] [Abstract][Full Text] [Related]
5. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis. He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075 [TBL] [Abstract][Full Text] [Related]
6. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study. He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175 [TBL] [Abstract][Full Text] [Related]
7. Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Koeberle D; Dufour JF; Demeter G; Li Q; Ribi K; Samaras P; Saletti P; Roth AD; Horber D; Buehlmann M; Wagner AD; Montemurro M; Lakatos G; Feilchenfeldt J; Peck-Radosavljevic M; Rauch D; Tschanz B; Bodoky G; Ann Oncol; 2016 May; 27(5):856-61. PubMed ID: 26884590 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination. El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089 [TBL] [Abstract][Full Text] [Related]
9. A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies. Harding JJ; Do RK; Dika IE; Hollywood E; Uhlitskykh K; Valentino E; Wan P; Hamilton C; Feng X; Johnston A; Bomalaski J; Li CF; O'Reilly EM; Abou-Alfa GK Cancer Chemother Pharmacol; 2018 Sep; 82(3):429-440. PubMed ID: 29971467 [TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial. Shi J; Sun J; Liu C; Chai Z; Wang N; Zhang H; Cheng S Trials; 2019 Apr; 20(1):245. PubMed ID: 31036040 [TBL] [Abstract][Full Text] [Related]
11. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. Li QJ; He MK; Chen HW; Fang WQ; Zhou YM; Xu L; Wei W; Zhang YJ; Guo Y; Guo RP; Chen MS; Shi M J Clin Oncol; 2022 Jan; 40(2):150-160. PubMed ID: 34648352 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib. El Dika I; Capanu M; Chou JF; Harding JJ; Ly M; Hrabovsky AD; Do RKG; Shia J; Millang B; Ma J; O'Reilly EM; Abou-Alfa GK Cancer Med; 2020 Oct; 9(20):7453-7459. PubMed ID: 32841541 [TBL] [Abstract][Full Text] [Related]
14. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y; Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy. Moore M; Gill S; Asmis T; Berry S; Burkes R; Zbuk K; Alcindor T; Jeyakumar A; Chan T; Rao S; Spratlin J; Tang PA; Rothenstein J; Chan E; Bendell J; Kudrik F; Kauh J; Tang S; Gao L; Kambhampati SR; Nasroulah F; Yang L; Ramdas N; Binder P; Strevel E Ann Oncol; 2016 Dec; 27(12):2216-2224. PubMed ID: 27733377 [TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. Lyu N; Kong Y; Mu L; Lin Y; Li J; Liu Y; Zhang Z; Zheng L; Deng H; Li S; Xie Q; Guo R; Shi M; Xu L; Cai X; Wu P; Zhao M J Hepatol; 2018 Jul; 69(1):60-69. PubMed ID: 29471013 [TBL] [Abstract][Full Text] [Related]
17. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. He M; Li Q; Zou R; Shen J; Fang W; Tan G; Zhou Y; Wu X; Xu L; Wei W; Le Y; Zhou Z; Zhao M; Guo Y; Guo R; Chen M; Shi M JAMA Oncol; 2019 Jul; 5(7):953-960. PubMed ID: 31070690 [TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma. Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma. Petrini I; Lencioni M; Ricasoli M; Iannopollo M; Orlandini C; Oliveri F; Bartolozzi C; Ricci S Cancer Chemother Pharmacol; 2012 Mar; 69(3):773-80. PubMed ID: 22033636 [TBL] [Abstract][Full Text] [Related]
20. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. Huang Y; Zhang L; He M; Lai Z; Bu X; Wen D; Li Q; Xu L; Wei W; Zhang Y; Zhou Z; Chen M; Guo R; Shi M; Kan A Technol Cancer Res Treat; 2022; 21():15330338221117389. PubMed ID: 36529949 [No Abstract] [Full Text] [Related] [Next] [New Search]